ITIH4 and AIDS: Similarly, the RBDs, including the CD4bs and CD4i, in the HIV-1 gp120 are also attractive targets for the development of AIDS vaccines because of the recent identification of several series of human broadly cross-reactive neutralizing antibodies targeting the CD4bs [34–38] and CD4i epitopes [39, 62, 70] in gp120.